Skip to main content
Top
Gepubliceerd in: Quality of Life Research 7/2016

01-07-2016

Validity of standard gamble utilities in patients referred for aortic valve replacement

Auteurs: Amjad I. Hussain, Andrew M. Garratt, Jan Otto Beitnes, Lars Gullestad, Kjell I. Pettersen

Gepubliceerd in: Quality of Life Research | Uitgave 7/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Standard gamble (SG) is the preferred method of assessing preferences in situations with uncertainty and risk, which makes it relevant to patients considered for aortic valve replacement (AVR). The present study assesses SG preferences in patients with severe aortic stenosis (AS).

Methods

All patients >18 years old with severe AS referred for AVR to our institution were invited to enroll in the study. The SG was administered by a clinical research nurse. The SF-36, EQ-5D 3L, Hospital Anxiety and Depression Scale (HADS), and AS symptoms were administered by self-completed questionnaire. We hypothesized that SG utilities would have low-to-moderate correlations with physical and mental aspects of health based on our pathophysiological understanding of severe AS. No correlations were expected with echocardiographic measures of the aortic valve.

Results

The response rate for SG was 98 %. SG moderately correlated with physical aspects of SF-36 (PCS, role-physical, vitality), health transition, AS symptoms, and EQ-VAS (ρ S = 0.31–0.39, p < 0.001) and had low correlation with mental aspects of SF-36 and EQ-5D (ρ S = 0.17–0.28, p < 0.001). No correlation was found between SG and HADS, echocardiographic measures, age, gender, or education level (ρ S = 0.01–0.06).

Conclusions

SG is an acceptable and feasible method of assessing preferences in patients with severe AS that has evidence for validity. The inclusion of uncertainty lends the SG face validity in this population as a direct approach to assessing preferences and basis for QALY calculations.
Literatuur
1.
go back to reference Leon, M. B., et al. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597–1607.CrossRefPubMed Leon, M. B., et al. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597–1607.CrossRefPubMed
2.
go back to reference Reynolds, M. R., et al. (2011). Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation, 124(18), 1964–1972.CrossRefPubMed Reynolds, M. R., et al. (2011). Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation, 124(18), 1964–1972.CrossRefPubMed
3.
go back to reference Barreto-Filho, J. A., et al. (2013). Trends in aortic valve replacement for elderly patients in the United States, 1999–2011. JAMA, 310(19), 2078–2085.CrossRefPubMedPubMedCentral Barreto-Filho, J. A., et al. (2013). Trends in aortic valve replacement for elderly patients in the United States, 1999–2011. JAMA, 310(19), 2078–2085.CrossRefPubMedPubMedCentral
4.
go back to reference Martinez-Selles, M., et al. (2014). Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. Journal of Internal Medicine, 275(6), 608–620.CrossRefPubMed Martinez-Selles, M., et al. (2014). Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. Journal of Internal Medicine, 275(6), 608–620.CrossRefPubMed
5.
go back to reference Gadey, G., & Reynolds, M. R. (2014). Cost-effectiveness considerations in transcatheter management of valvular heart disease. Canadian Journal of Cardiology, 30(9), 1058–1063.CrossRefPubMed Gadey, G., & Reynolds, M. R. (2014). Cost-effectiveness considerations in transcatheter management of valvular heart disease. Canadian Journal of Cardiology, 30(9), 1058–1063.CrossRefPubMed
7.
go back to reference Torrance, G. W., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5(4), 559–575.CrossRefPubMed Torrance, G. W., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5(4), 559–575.CrossRefPubMed
8.
go back to reference Drummond, M. F., et al. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press. Drummond, M. F., et al. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
9.
go back to reference Torrance, G. W., Furlong, W., & Feeny, D. (2002). Health utility estimation. Expert Review of Pharmacoeconomics & Outcomes Research, 2(2), 99–108.CrossRef Torrance, G. W., Furlong, W., & Feeny, D. (2002). Health utility estimation. Expert Review of Pharmacoeconomics & Outcomes Research, 2(2), 99–108.CrossRef
10.
go back to reference Gafni, A. (1994). The standard gamble method: what is being measured and how it is interpreted. Health Services Research, 29(2), 207–224.PubMedPubMedCentral Gafni, A. (1994). The standard gamble method: what is being measured and how it is interpreted. Health Services Research, 29(2), 207–224.PubMedPubMedCentral
11.
go back to reference Torrance, G. W., et al. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702–722.CrossRefPubMed Torrance, G. W., et al. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702–722.CrossRefPubMed
12.
go back to reference Green, C., Brazier, J., & Deverill, M. (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151–165.CrossRefPubMed Green, C., Brazier, J., & Deverill, M. (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151–165.CrossRefPubMed
13.
go back to reference Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 health survey: (standard & acute forms). Lincolm, RI: QualityMetric Inc. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 health survey: (standard & acute forms). Lincolm, RI: QualityMetric Inc.
14.
go back to reference McHorney, C. A., Ware, J. E, Jr, & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.CrossRefPubMed McHorney, C. A., Ware, J. E, Jr, & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.CrossRefPubMed
15.
go back to reference Falcoz, P. E., et al. (2002). Comparison of the Nottingham Health Profile and the 36-item health survey questionnaires in cardiac surgery. Annals of Thoracic Surgery, 73(4), 1222–1228.CrossRefPubMed Falcoz, P. E., et al. (2002). Comparison of the Nottingham Health Profile and the 36-item health survey questionnaires in cardiac surgery. Annals of Thoracic Surgery, 73(4), 1222–1228.CrossRefPubMed
16.
go back to reference Tseng, E. E., et al. (1997). Aortic valve replacement in the elderly. Risk factors and long-term results. Annals of Surgery, 225(6), 793–802. (discussion 802-4).CrossRefPubMedPubMedCentral Tseng, E. E., et al. (1997). Aortic valve replacement in the elderly. Risk factors and long-term results. Annals of Surgery, 225(6), 793–802. (discussion 802-4).CrossRefPubMedPubMedCentral
17.
go back to reference Sundt, T. M., et al. (2000). Quality of life after aortic valve replacement at the age of >80 years. Circulation, 102(19 Suppl 3), Iii70-4.PubMed Sundt, T. M., et al. (2000). Quality of life after aortic valve replacement at the age of >80 years. Circulation, 102(19 Suppl 3), Iii70-4.PubMed
18.
go back to reference Loge, J. H., & Kaasa, S. (1998). Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scandinavian Journal of Social Medicine, 26(4), 250–258.PubMed Loge, J. H., & Kaasa, S. (1998). Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scandinavian Journal of Social Medicine, 26(4), 250–258.PubMed
19.
go back to reference Karlsen, T. I., et al. (2011). Validity of the SF-36 in patients with morbid obesity. Obesity Facts, 4(5), 346–351.CrossRefPubMed Karlsen, T. I., et al. (2011). Validity of the SF-36 in patients with morbid obesity. Obesity Facts, 4(5), 346–351.CrossRefPubMed
20.
go back to reference Fredheim, O. M., et al. (2007). Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management, 34(6), 657–665.CrossRefPubMed Fredheim, O. M., et al. (2007). Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management, 34(6), 657–665.CrossRefPubMed
21.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed
22.
go back to reference The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
23.
go back to reference Brazier, J., et al. (2003). Use of visual analog scales in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research, 3(3), 293–302.CrossRef Brazier, J., et al. (2003). Use of visual analog scales in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research, 3(3), 293–302.CrossRef
24.
go back to reference Torrance, G. W., Feeny, D., & Furlong, W. (2001). Visual analog scales: Do they have a role in the measurement of preferences for health states? Medical Decision Making, 21(4), 329–334.CrossRefPubMed Torrance, G. W., Feeny, D., & Furlong, W. (2001). Visual analog scales: Do they have a role in the measurement of preferences for health states? Medical Decision Making, 21(4), 329–334.CrossRefPubMed
25.
go back to reference Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences—II: Scaling methods. Journal of Clinical Epidemiology, 42(5), 459–471.CrossRefPubMed Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences—II: Scaling methods. Journal of Clinical Epidemiology, 42(5), 459–471.CrossRefPubMed
26.
go back to reference Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale—A review of validation data and clinical results. Journal of Psychosomatic Research, 42(1), 17–41.CrossRefPubMed Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale—A review of validation data and clinical results. Journal of Psychosomatic Research, 42(1), 17–41.CrossRefPubMed
27.
go back to reference New York Heart Association Criteria, C. (1979). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston: Little, Brown. New York Heart Association Criteria, C. (1979). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston: Little, Brown.
28.
go back to reference Lang, R. M., et al. (2005). Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18(12), 1440–1463.CrossRefPubMed Lang, R. M., et al. (2005). Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18(12), 1440–1463.CrossRefPubMed
29.
go back to reference Quinones, M. A., et al. (2002). Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography, 15(2), 167–184.CrossRefPubMed Quinones, M. A., et al. (2002). Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography, 15(2), 167–184.CrossRefPubMed
30.
go back to reference Chesebro, J. H., et al. (1987). Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical Findings through hospital discharge. Circulation, 76(1), 142–154.CrossRefPubMed Chesebro, J. H., et al. (1987). Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical Findings through hospital discharge. Circulation, 76(1), 142–154.CrossRefPubMed
31.
go back to reference Charlson, M. E., et al. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.CrossRefPubMed Charlson, M. E., et al. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.CrossRefPubMed
32.
go back to reference Charlson, M., et al. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology, 47(11), 1245–1251.CrossRefPubMed Charlson, M., et al. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology, 47(11), 1245–1251.CrossRefPubMed
33.
go back to reference Brazier, J., & Deverill, M. (1999). A checklist for judging preference-based measures of health related quality of life: Learning from psychometrics. Health Economics, 8(1), 41–51.CrossRefPubMed Brazier, J., & Deverill, M. (1999). A checklist for judging preference-based measures of health related quality of life: Learning from psychometrics. Health Economics, 8(1), 41–51.CrossRefPubMed
34.
go back to reference Dolan, P., et al. (1996). The time trade-off method: Results from a general population study. Health Economics, 5(2), 141–154.CrossRefPubMed Dolan, P., et al. (1996). The time trade-off method: Results from a general population study. Health Economics, 5(2), 141–154.CrossRefPubMed
35.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Laurence Erlbaum. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Laurence Erlbaum.
36.
go back to reference Bennett, J. A., et al. (2002). Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung: The Journal of Acute and Critical Care, 31(4), 262–270.CrossRefPubMed Bennett, J. A., et al. (2002). Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung: The Journal of Acute and Critical Care, 31(4), 262–270.CrossRefPubMed
37.
38.
go back to reference Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer Netherlands.CrossRef Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer Netherlands.CrossRef
39.
go back to reference Slevin, M. L., et al. (1990). Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ, 300(6737), 1458–1460.CrossRefPubMedPubMedCentral Slevin, M. L., et al. (1990). Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ, 300(6737), 1458–1460.CrossRefPubMedPubMedCentral
40.
go back to reference Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 40(6), 593–603.CrossRefPubMed Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 40(6), 593–603.CrossRefPubMed
41.
go back to reference Bleichrodt, H., & Johannesson, M. (1997). An experimental test of a theoretical foundation for rating-scale valuations. Medical Decision Making, 17(2), 208–216.CrossRefPubMed Bleichrodt, H., & Johannesson, M. (1997). An experimental test of a theoretical foundation for rating-scale valuations. Medical Decision Making, 17(2), 208–216.CrossRefPubMed
42.
go back to reference van der Donk, J., et al. (1995). Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: A comparison of state and process utilities. Journal of Clinical Oncology, 13(9), 2369–2378.PubMed van der Donk, J., et al. (1995). Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: A comparison of state and process utilities. Journal of Clinical Oncology, 13(9), 2369–2378.PubMed
43.
go back to reference Rutten-van Molken, M. P., et al. (1995). Methodological issues of patient utility measurement. Experience from two clinical trials. Medical Care, 33(9), 922–937.CrossRefPubMed Rutten-van Molken, M. P., et al. (1995). Methodological issues of patient utility measurement. Experience from two clinical trials. Medical Care, 33(9), 922–937.CrossRefPubMed
44.
go back to reference Clarke, A. E., et al. (1997). The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Quality of Life Research, 6(2), 169–184.CrossRefPubMed Clarke, A. E., et al. (1997). The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Quality of Life Research, 6(2), 169–184.CrossRefPubMed
45.
go back to reference Zug, K. A., et al. (1995). Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Archives of Dermatology, 131(5), 561–568.CrossRefPubMed Zug, K. A., et al. (1995). Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Archives of Dermatology, 131(5), 561–568.CrossRefPubMed
46.
go back to reference Nishimura, R. A., et al. (2014). 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), e521–e643.CrossRefPubMed Nishimura, R. A., et al. (2014). 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), e521–e643.CrossRefPubMed
47.
go back to reference Lloyd, A., et al. (2008). Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations. Value in Health, 11(7), 1178–1185.CrossRefPubMed Lloyd, A., et al. (2008). Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations. Value in Health, 11(7), 1178–1185.CrossRefPubMed
48.
go back to reference McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy, 84(2–3), 321–331.CrossRefPubMed McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy, 84(2–3), 321–331.CrossRefPubMed
49.
go back to reference Reynolds, M. R., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). Journal of the American College of Cardiology, 60(25), 2683–2692.CrossRefPubMed Reynolds, M. R., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). Journal of the American College of Cardiology, 60(25), 2683–2692.CrossRefPubMed
50.
go back to reference Watt, M., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart, 98(5), 370–376.CrossRefPubMed Watt, M., et al. (2012). Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart, 98(5), 370–376.CrossRefPubMed
51.
go back to reference Singer, L. G., Theodore, J., & Gould, M. K. (2003). Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Medical Decision Making, 23(5), 435–440.CrossRefPubMed Singer, L. G., Theodore, J., & Gould, M. K. (2003). Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Medical Decision Making, 23(5), 435–440.CrossRefPubMed
52.
go back to reference Nease, R. F, Jr, et al. (1995). Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA, 273(15), 1185–1190.CrossRefPubMed Nease, R. F, Jr, et al. (1995). Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA, 273(15), 1185–1190.CrossRefPubMed
53.
go back to reference Dolan, P., & Sutton, M. (1997). Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Social Science and Medicine, 44(10), 1519–1530.CrossRefPubMed Dolan, P., & Sutton, M. (1997). Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Social Science and Medicine, 44(10), 1519–1530.CrossRefPubMed
54.
go back to reference Doctor, J. N., Bleichrodt, H., & Lin, H. J. (2010). Health utility bias: A systematic review and meta-analytic evaluation. Medical Decision Making, 30(1), 58–67.CrossRefPubMed Doctor, J. N., Bleichrodt, H., & Lin, H. J. (2010). Health utility bias: A systematic review and meta-analytic evaluation. Medical Decision Making, 30(1), 58–67.CrossRefPubMed
55.
go back to reference Tversky, A., & Kahneman, D. (1981). The framing of decisions and the psychology of choice. Science, 211(4481), 453–458.CrossRefPubMed Tversky, A., & Kahneman, D. (1981). The framing of decisions and the psychology of choice. Science, 211(4481), 453–458.CrossRefPubMed
56.
go back to reference Gerard, K., Dobson, M., & Hall, J. (1993). Framing and labelling effects in health descriptions: Quality adjusted life years for treatment of breast cancer. Journal of Clinical Epidemiology, 46(1), 77–84.CrossRefPubMed Gerard, K., Dobson, M., & Hall, J. (1993). Framing and labelling effects in health descriptions: Quality adjusted life years for treatment of breast cancer. Journal of Clinical Epidemiology, 46(1), 77–84.CrossRefPubMed
Metagegevens
Titel
Validity of standard gamble utilities in patients referred for aortic valve replacement
Auteurs
Amjad I. Hussain
Andrew M. Garratt
Jan Otto Beitnes
Lars Gullestad
Kjell I. Pettersen
Publicatiedatum
01-07-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1186-1

Andere artikelen Uitgave 7/2016

Quality of Life Research 7/2016 Naar de uitgave